Large genomic deletions inactivate the BRCA2 gene in breast cancer families. 2005

S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
Department of Oncology and Surgical Sciences, Oncology Section, Padua, Italy.

BACKGROUND BRCA1 and BRCA2 are the two major genes responsible for the breast and ovarian cancers that cluster in families with a genetically determined predisposition. However, regardless of the mutation detection method employed, the percentage of families without identifiable alterations of these genes exceeds 50%, even when applying stringent criteria for family selection. A small but significant increase in mutation detection rate has resulted from the discovery of large genomic alterations in BRCA1. A few studies have addressed the question of whether BRCA2 might be inactivated by the same kinds of alteration, but most were either done on a relatively small number of samples or employed cumbersome mutation detection methods of variable sensitivity. OBJECTIVE To analyse 121 highly selected families using the recently available BRCA2 multiplex ligation dependent probe amplification (MLPA) technique. RESULTS Three different large genomic deletions were identified and confirmed by analysis of the mutant transcript and genomic characterisation of the breakpoints. CONCLUSIONS Contrary to initial suggestions, the presence of BRCA2 genomic rearrangements is worth investigating in high risk breast or ovarian cancer families.

UI MeSH Term Description Entries
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
November 2010, Breast cancer research and treatment,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
May 2009, Breast cancer research and treatment,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
May 2008, BMC cancer,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
December 2013, Molecular biology reports,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
January 2006, Cancer detection and prevention,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
September 2001, Cancer genetics and cytogenetics,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
May 2007, Breast cancer research and treatment,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
December 2004, Human mutation,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
September 2010, Breast cancer research and treatment,
S Agata, and M Dalla Palma, and M Callegaro, and M C Scaini, and C Menin, and C Ghiotto, and O Nicoletto, and G Zavagno, and L Chieco-Bianchi, and E D'Andrea, and M Montagna
May 1996, Nature genetics,
Copied contents to your clipboard!